Advertisement
Advertisement

INAB

INAB logo

IN8bio Inc

0.2709
USD
-0.0171
-5.94%
Dec 18, 15:39 UTC -5
Closed
...

IN8bio Inc Profile

About

IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage. IN8bio Inc. is based in New York.

Info & Links

CEO

William Ho

Headquarters

350 5th Avenue, Suite 5330
New York, NY 10118, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.in8bio.com

Auditor

CohnReznick LLP

Share holders

37

Employees

31

IN8bio Inc Statistics

Valuation Measures

Market Capitalization2

19.63M

Enterprise Value

16.84M

Enterprise Value/EBITDA(ttm)

-0.57

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.55

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-197.15%

Return on Invested Capital(ttm)

-217.58%

Return on Assets(ttm)

-130.48%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-29.46M

Net Income Available to Common(ttm)

-31.88M

Diluted EPS(ttm)

-0.75

Share Statistics

Beta (5Y Monthly)

0.01

52-Week Change

-69.90%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

72.48M

Dividend Yield

0.00%

Float4

61.25M

% Held by Insiders

15.50%

% Held by Institutions

92.05%

Balance Sheet

Total Cash(mrq)

4.00M

Total Cash Per Share(mrq)

0.06

Total Debt(mrq)

1.21M

Total Debt/Equity(mrq)

14.07%

Current Ratio(mrq)

1.84%

Quick Ratio(mrq)

1.84%

Book Value Per Share(mrq)

0.18

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.43

Free Cash Flow(ytd)

-20.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement